Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Goodwill: 2020-2025

Historic Goodwill for Northwest Biotherapeutics (NWBO) over the last 5 years, with Sep 2025 value amounting to $626,000.

  • Northwest Biotherapeutics' Goodwill changed negligibly% to $626,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $626,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $626,000 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Northwest Biotherapeutics' Goodwill stood at $626,000, which was down 0.00% from $626,000 recorded in Q2 2025.
  • Northwest Biotherapeutics' 5-year Goodwill high stood at $626,000 for Q1 2021, and its period low was $626,000 during Q1 2021.
  • Over the past 3 years, Northwest Biotherapeutics' median Goodwill value was $626,000 (recorded in 2025), while the average stood at $626,000.
  • Data for Northwest Biotherapeutics' Goodwill shows a maximum YoY dropped of 4.28% (in 2021) over the last 5 years.
  • Over the past 5 years, Northwest Biotherapeutics' Goodwill (Quarterly) stood at $626,000 in 2021, then remained steady at $626,000 in 2022, then remained steady at $626,000 in 2023, then remained steady at $626,000 in 2024, then remained steady at $626,000 in 2025.
  • Its last three reported values are $626,000 in Q3 2025, $626,000 for Q2 2025, and $626,000 during Q1 2025.